Actively Recruiting
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
Led by Shanghai Eye Disease Prevention and Treatment Center · Updated on 2024-12-04
108
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.
CONDITIONS
Official Title
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 8 and 10 years old
- Low myopia with cycloplegic spherical equivalent refractions from -0.50 to -3.00 diopters and less than -2.5 diopters astigmatism in either eye
- Signed informed consent and ability to participate in the study
You will not qualify if you...
- Secondary myopia from conditions like retinopathy of prematurity or genetic disorders such as Stickler or Marfan syndrome
- Strabismus or other binocular vision abnormalities
- Cloudy refractive media including cloudy cornea, cataract, or history of intraocular lens surgery
- Eye diseases affecting retinal function including macular degeneration, diabetic retinopathy, retinal detachment, glaucoma, ocular hypertension, uveitis, optic neuropathy, or endophthalmitis
- History of refractive or internal eye surgery, laser therapy, or vitreous injection
- Systemic disorders such as diabetes or hypertension
- History of using retinal toxic drugs like hydroxychloroquine
- Current use of myopia control treatments like orthokeratology, atropine, or multifocal glasses unless stopped for at least 2 weeks
- Other ocular or systemic diseases or abnormalities deemed unsuitable by the study physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China, 200041
Actively Recruiting
Research Team
X
Xiangui He, Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here